Antigen-scaffolds loaded with hyper-stable neoleukin-2/15 expand antigen-specific T cells with a favorable phenotype for adoptive cell therapy.

Ormhøj M, Munk KK, Tvingsholm S, Ramanathan K, Bentzen AK, Kladis G, Aasbjerg GN, Nos G, Tamhane T, Halldórsdóttir HR, Jakobsen SN, Frej MS, Johansen KH, Kadivar M, Hadrup SR.

Open source

DOI
10.3389/fimmu.2026.1804678
Published
2026-06-11
Container
Front Immunol
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1804678,
  title = {Antigen-scaffolds loaded with hyper-stable neoleukin-2/15 expand antigen-specific T cells with a favorable phenotype for adoptive cell therapy.},
  author = {Ormhøj M and  Munk KK and  Tvingsholm S and  Ramanathan K and  Bentzen AK and  Kladis G and  Aasbjerg GN and  Nos G and  Tamhane T and  Halldórsdóttir HR and  Jakobsen SN and  Frej MS and  Johansen KH and  Kadivar M and  Hadrup SR.},
  year = {2026},
  journal = {Front Immunol},
  doi = {10.3389/fimmu.2026.1804678},
  url = {https://doi.org/10.3389/fimmu.2026.1804678}
}

RIS

TY  - JOUR
TI  - Antigen-scaffolds loaded with hyper-stable neoleukin-2/15 expand antigen-specific T cells with a favorable phenotype for adoptive cell therapy.
AU  - Ormhøj M
AU  -  Munk KK
AU  -  Tvingsholm S
AU  -  Ramanathan K
AU  -  Bentzen AK
AU  -  Kladis G
AU  -  Aasbjerg GN
AU  -  Nos G
AU  -  Tamhane T
AU  -  Halldórsdóttir HR
AU  -  Jakobsen SN
AU  -  Frej MS
AU  -  Johansen KH
AU  -  Kadivar M
AU  -  Hadrup SR.
PY  - 2026
JO  - Front Immunol
DO  - 10.3389/fimmu.2026.1804678
UR  - https://doi.org/10.3389/fimmu.2026.1804678
ER  - 

APA

M, O., KK, M., S, T., K, R., AK, B., G, K., GN, A., G, N., T, T., HR, H., SN, J., MS, F., KH, J., M, K., & SR., H. (2026). Antigen-scaffolds loaded with hyper-stable neoleukin-2/15 expand antigen-specific T cells with a favorable phenotype for adoptive cell therapy.. Front Immunol. https://doi.org/10.3389/fimmu.2026.1804678

Source records